Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2
Prior studies have shown that PI3Ks play a necessary but incompletely defined role in platelet activation. One potential effector for PI3K is the serine/threonine kinase, Akt, whose contribution to platelet activation was explored here. Two isoforms of Akt were detected in mouse platelets, with expr...
Gespeichert in:
Veröffentlicht in: | The Journal of clinical investigation 2004-02, Vol.113 (3), p.441-450 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 450 |
---|---|
container_issue | 3 |
container_start_page | 441 |
container_title | The Journal of clinical investigation |
container_volume | 113 |
creator | Woulfe, Donna Jiang, Hong Morgans, Alicia Monks, Robert Birnbaum, Morris Brass, Lawrence F |
description | Prior studies have shown that PI3Ks play a necessary but incompletely defined role in platelet activation. One potential effector for PI3K is the serine/threonine kinase, Akt, whose contribution to platelet activation was explored here. Two isoforms of Akt were detected in mouse platelets, with expression of Akt2 being greater than Akt1. Deletion of the gene encoding Akt2 impaired platelet aggregation, fibrinogen binding, and granule secretion, especially in response to low concentrations of agonists that activate the G(q)-coupled receptors for thrombin and thromboxane A(2). Loss of Akt2 also impaired arterial thrombus formation and stability in vivo, despite having little effect on platelet responses to collagen and ADP. In contrast, reducing Akt1 expression had no effect except when Akt2 was also deleted. Activation of Akt by thrombin was abolished by deletion of Galpha(q) but was relatively unaffected by deletion of Galpha(i2), which abolished Akt activation by ADP. From these results we conclude that Akt2 is a necessary component of PI3K-dependent signaling downstream of G(q)-coupled receptors, promoting thrombus growth and stability in part by supporting secretion. The contribution of Akt1 is less evident except in the setting in which Akt2 is absent. |
doi_str_mv | 10.1172/jci200420267 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_324545</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80138701</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-75f6c707a307b01b59f0aa084d011da6c213a561df8e2e92862ece49191a61133</originalsourceid><addsrcrecordid>eNqFkUFv1DAQRi1ERbeFG2cUceDUlBk7jp0Dh2qhUFSJCxyR5XUmqbdJvNgJEv8eL12VlgsXW_a8b2TPY-wlwjmi4m-3znOAigOv1RO2Qil1qbnQT9kKgGPZKKGP2UlKWwCsKlk9Y8dYKSlFhSv2_T115OZU-KlI5CLNPkxnhe37SL09HKa2mG9iGDdLKroQxz_3-8RusDMNlONdLhejd1QM1t36qS8ubmf-nB11dkj04rCfsm-XH76uP5XXXz5erS-uSydBzKWSXe0UKCtAbQA3sunAWtBVC4itrR1HYWWNbaeJU8N1zclR1WCDtkYU4pS9u-u7WzYjtY6mOdrB7KIfbfxlgvXmcWXyN6YPP43geSAy598c8jH8WCjNZvTJ0TDYicKSjAYUWuXlfyAq3WiNPIOv_wG3YYlTHoLJtmRWIffdzu4gF0NKkbr7FyOYvVzzeX11Lzfjrx7-8i98sCl-A_bPnyo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200500151</pqid></control><display><type>article</type><title>Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Woulfe, Donna ; Jiang, Hong ; Morgans, Alicia ; Monks, Robert ; Birnbaum, Morris ; Brass, Lawrence F</creator><creatorcontrib>Woulfe, Donna ; Jiang, Hong ; Morgans, Alicia ; Monks, Robert ; Birnbaum, Morris ; Brass, Lawrence F</creatorcontrib><description>Prior studies have shown that PI3Ks play a necessary but incompletely defined role in platelet activation. One potential effector for PI3K is the serine/threonine kinase, Akt, whose contribution to platelet activation was explored here. Two isoforms of Akt were detected in mouse platelets, with expression of Akt2 being greater than Akt1. Deletion of the gene encoding Akt2 impaired platelet aggregation, fibrinogen binding, and granule secretion, especially in response to low concentrations of agonists that activate the G(q)-coupled receptors for thrombin and thromboxane A(2). Loss of Akt2 also impaired arterial thrombus formation and stability in vivo, despite having little effect on platelet responses to collagen and ADP. In contrast, reducing Akt1 expression had no effect except when Akt2 was also deleted. Activation of Akt by thrombin was abolished by deletion of Galpha(q) but was relatively unaffected by deletion of Galpha(i2), which abolished Akt activation by ADP. From these results we conclude that Akt2 is a necessary component of PI3K-dependent signaling downstream of G(q)-coupled receptors, promoting thrombus growth and stability in part by supporting secretion. The contribution of Akt1 is less evident except in the setting in which Akt2 is absent.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/jci200420267</identifier><identifier>PMID: 14755341</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>ADP ; Akt2 protein ; Animals ; Biomedical research ; Bleeding Time ; Blood clots ; Blood Coagulation - genetics ; Blood Coagulation - physiology ; Blood platelets ; Blood Platelets - metabolism ; Fibrinogen - metabolism ; Kinases ; Mice ; Platelet Activation - genetics ; Platelet Activation - physiology ; Platelet Aggregation - genetics ; Platelet Aggregation - physiology ; Protein Isoforms ; Protein-Serine-Threonine Kinases ; Proteins ; Proto-Oncogene Proteins - deficiency ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Proto-Oncogene Proteins c-akt ; RNA, Messenger - metabolism ; Thrombosis - metabolism</subject><ispartof>The Journal of clinical investigation, 2004-02, Vol.113 (3), p.441-450</ispartof><rights>Copyright American Society for Clinical Investigation Feb 2004</rights><rights>Copyright © 2004, American Society for Clinical Investigation 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-75f6c707a307b01b59f0aa084d011da6c213a561df8e2e92862ece49191a61133</citedby><cites>FETCH-LOGICAL-c503t-75f6c707a307b01b59f0aa084d011da6c213a561df8e2e92862ece49191a61133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC324545/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC324545/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14755341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Woulfe, Donna</creatorcontrib><creatorcontrib>Jiang, Hong</creatorcontrib><creatorcontrib>Morgans, Alicia</creatorcontrib><creatorcontrib>Monks, Robert</creatorcontrib><creatorcontrib>Birnbaum, Morris</creatorcontrib><creatorcontrib>Brass, Lawrence F</creatorcontrib><title>Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Prior studies have shown that PI3Ks play a necessary but incompletely defined role in platelet activation. One potential effector for PI3K is the serine/threonine kinase, Akt, whose contribution to platelet activation was explored here. Two isoforms of Akt were detected in mouse platelets, with expression of Akt2 being greater than Akt1. Deletion of the gene encoding Akt2 impaired platelet aggregation, fibrinogen binding, and granule secretion, especially in response to low concentrations of agonists that activate the G(q)-coupled receptors for thrombin and thromboxane A(2). Loss of Akt2 also impaired arterial thrombus formation and stability in vivo, despite having little effect on platelet responses to collagen and ADP. In contrast, reducing Akt1 expression had no effect except when Akt2 was also deleted. Activation of Akt by thrombin was abolished by deletion of Galpha(q) but was relatively unaffected by deletion of Galpha(i2), which abolished Akt activation by ADP. From these results we conclude that Akt2 is a necessary component of PI3K-dependent signaling downstream of G(q)-coupled receptors, promoting thrombus growth and stability in part by supporting secretion. The contribution of Akt1 is less evident except in the setting in which Akt2 is absent.</description><subject>ADP</subject><subject>Akt2 protein</subject><subject>Animals</subject><subject>Biomedical research</subject><subject>Bleeding Time</subject><subject>Blood clots</subject><subject>Blood Coagulation - genetics</subject><subject>Blood Coagulation - physiology</subject><subject>Blood platelets</subject><subject>Blood Platelets - metabolism</subject><subject>Fibrinogen - metabolism</subject><subject>Kinases</subject><subject>Mice</subject><subject>Platelet Activation - genetics</subject><subject>Platelet Activation - physiology</subject><subject>Platelet Aggregation - genetics</subject><subject>Platelet Aggregation - physiology</subject><subject>Protein Isoforms</subject><subject>Protein-Serine-Threonine Kinases</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins - deficiency</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Proto-Oncogene Proteins c-akt</subject><subject>RNA, Messenger - metabolism</subject><subject>Thrombosis - metabolism</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkUFv1DAQRi1ERbeFG2cUceDUlBk7jp0Dh2qhUFSJCxyR5XUmqbdJvNgJEv8eL12VlgsXW_a8b2TPY-wlwjmi4m-3znOAigOv1RO2Qil1qbnQT9kKgGPZKKGP2UlKWwCsKlk9Y8dYKSlFhSv2_T115OZU-KlI5CLNPkxnhe37SL09HKa2mG9iGDdLKroQxz_3-8RusDMNlONdLhejd1QM1t36qS8ubmf-nB11dkj04rCfsm-XH76uP5XXXz5erS-uSydBzKWSXe0UKCtAbQA3sunAWtBVC4itrR1HYWWNbaeJU8N1zclR1WCDtkYU4pS9u-u7WzYjtY6mOdrB7KIfbfxlgvXmcWXyN6YPP43geSAy598c8jH8WCjNZvTJ0TDYicKSjAYUWuXlfyAq3WiNPIOv_wG3YYlTHoLJtmRWIffdzu4gF0NKkbr7FyOYvVzzeX11Lzfjrx7-8i98sCl-A_bPnyo</recordid><startdate>200402</startdate><enddate>200402</enddate><creator>Woulfe, Donna</creator><creator>Jiang, Hong</creator><creator>Morgans, Alicia</creator><creator>Monks, Robert</creator><creator>Birnbaum, Morris</creator><creator>Brass, Lawrence F</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200402</creationdate><title>Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2</title><author>Woulfe, Donna ; Jiang, Hong ; Morgans, Alicia ; Monks, Robert ; Birnbaum, Morris ; Brass, Lawrence F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-75f6c707a307b01b59f0aa084d011da6c213a561df8e2e92862ece49191a61133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>ADP</topic><topic>Akt2 protein</topic><topic>Animals</topic><topic>Biomedical research</topic><topic>Bleeding Time</topic><topic>Blood clots</topic><topic>Blood Coagulation - genetics</topic><topic>Blood Coagulation - physiology</topic><topic>Blood platelets</topic><topic>Blood Platelets - metabolism</topic><topic>Fibrinogen - metabolism</topic><topic>Kinases</topic><topic>Mice</topic><topic>Platelet Activation - genetics</topic><topic>Platelet Activation - physiology</topic><topic>Platelet Aggregation - genetics</topic><topic>Platelet Aggregation - physiology</topic><topic>Protein Isoforms</topic><topic>Protein-Serine-Threonine Kinases</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins - deficiency</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Proto-Oncogene Proteins c-akt</topic><topic>RNA, Messenger - metabolism</topic><topic>Thrombosis - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woulfe, Donna</creatorcontrib><creatorcontrib>Jiang, Hong</creatorcontrib><creatorcontrib>Morgans, Alicia</creatorcontrib><creatorcontrib>Monks, Robert</creatorcontrib><creatorcontrib>Birnbaum, Morris</creatorcontrib><creatorcontrib>Brass, Lawrence F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woulfe, Donna</au><au>Jiang, Hong</au><au>Morgans, Alicia</au><au>Monks, Robert</au><au>Birnbaum, Morris</au><au>Brass, Lawrence F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2004-02</date><risdate>2004</risdate><volume>113</volume><issue>3</issue><spage>441</spage><epage>450</epage><pages>441-450</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Prior studies have shown that PI3Ks play a necessary but incompletely defined role in platelet activation. One potential effector for PI3K is the serine/threonine kinase, Akt, whose contribution to platelet activation was explored here. Two isoforms of Akt were detected in mouse platelets, with expression of Akt2 being greater than Akt1. Deletion of the gene encoding Akt2 impaired platelet aggregation, fibrinogen binding, and granule secretion, especially in response to low concentrations of agonists that activate the G(q)-coupled receptors for thrombin and thromboxane A(2). Loss of Akt2 also impaired arterial thrombus formation and stability in vivo, despite having little effect on platelet responses to collagen and ADP. In contrast, reducing Akt1 expression had no effect except when Akt2 was also deleted. Activation of Akt by thrombin was abolished by deletion of Galpha(q) but was relatively unaffected by deletion of Galpha(i2), which abolished Akt activation by ADP. From these results we conclude that Akt2 is a necessary component of PI3K-dependent signaling downstream of G(q)-coupled receptors, promoting thrombus growth and stability in part by supporting secretion. The contribution of Akt1 is less evident except in the setting in which Akt2 is absent.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>14755341</pmid><doi>10.1172/jci200420267</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9738 |
ispartof | The Journal of clinical investigation, 2004-02, Vol.113 (3), p.441-450 |
issn | 0021-9738 1558-8238 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_324545 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | ADP Akt2 protein Animals Biomedical research Bleeding Time Blood clots Blood Coagulation - genetics Blood Coagulation - physiology Blood platelets Blood Platelets - metabolism Fibrinogen - metabolism Kinases Mice Platelet Activation - genetics Platelet Activation - physiology Platelet Aggregation - genetics Platelet Aggregation - physiology Protein Isoforms Protein-Serine-Threonine Kinases Proteins Proto-Oncogene Proteins - deficiency Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Proto-Oncogene Proteins c-akt RNA, Messenger - metabolism Thrombosis - metabolism |
title | Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A45%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defects%20in%20secretion,%20aggregation,%20and%20thrombus%20formation%20in%20platelets%20from%20mice%20lacking%20Akt2&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Woulfe,%20Donna&rft.date=2004-02&rft.volume=113&rft.issue=3&rft.spage=441&rft.epage=450&rft.pages=441-450&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/jci200420267&rft_dat=%3Cproquest_pubme%3E80138701%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200500151&rft_id=info:pmid/14755341&rfr_iscdi=true |